Brian Taylor Slingsby insider trades
Open-market stock purchases and sales by Brian Taylor Slingsby, Director at Mineralys Therapeutics, Inc, from SEC Form 4 filings since Feb 9, 2023.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +77%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 22, 2026 | MLYS Mineralys Therapeutics, Inc | Sold | $3M |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc | Bought (not open market) | — |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc | Bought (not open market) | — |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc | Bought (not open market) | — |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc | Bought (not open market) | — |
| Nov 20, 2025 | MLYS Mineralys Therapeutics, Inc | Sold | $43.4M |
Companies traded
- MLYS Mineralys Therapeutics, Inc: 2 buys, 3 sales, last Sep 22, 2026
Get free alerts when Brian Taylor Slingsby files a new trade →